Candel Therapeutics Inc. (CADL) PT Raised to $25 at Canaccord Genuity
Tweet
Share
E-mailGet Alerts CADL Hot Sheet
Price: $11.72 -0.68%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity analyst John Newman raised the price target on Candel Therapeutics Inc. (NASDAQ: CADL) to $25.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- Candel Therapeutics Inc. (CADL) PT Raised to $12 at BofA Securities
- Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
